Eli Lilly (LLY) earnings

Earnings (net income) · fiscal 2025
$20.64B

Eli Lilly (LLY) reported net income of $20.64B in fiscal 2025 (the year ended December 31, 2025). That is 94.9% higher than the $10.59B of fiscal 2024. Figures as of 17 Nov 2026, 17:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$20.64B
Change on fiscal 2024
+94.9%
Growth, 5 years
+27.2% a year
Growth, 10 years
+24.0% a year
Highest on record
$20.64Bfiscal 2025
Lowest on record
-$2.07Bfiscal 2008
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Eli Lilly earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 27.2% a year; over ten years the rate was 24.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $20.64B in fiscal 2025 and the lowest -$2.07B in fiscal 2008.

History · 19 fiscal years

Earnings (net income) by fiscal year

Eli Lilly earnings, year by year

Eli Lilly (LLY) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$20.64B 94.9% up
2024$10.59B 102.1% up
2023$5.24B 16.1% down
2022$6.24B 11.9% up
2021$5.58B 9.9% down
2020$6.19B 25.5% down
2019$8.32B 157.4% up
2018$3.23B—
2017-$204.10M 107.5% down
2016$2.74B 13.7% up
2015$2.41B 0.7% up
2014$2.39B 49.0% down
2013$4.68B 14.6% up
2012$4.09B 6.0% down
2011$4.35B 14.2% down
2010$5.07B 17.1% up
2009$4.33B—
2008-$2.07B 170.2% down
2007$2.95B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Eli Lilly and comparable companies
CompanyEarnings (net income)Fiscal year
Eli Lilly LLY$20.64B2025
Johnson & Johnson JNJ$26.80B2025
AbbVie ABBV$4.23B2025
Merck & Co MRK$18.25B2025
UnitedHealth Group UNH$12.06B2025
Novartis NVS$13.98B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LLY

Eli Lilly, figure by figure

Eli Lilly (LLY) overview: price, valuation and scorecardAll health care companies by market value

Eli Lilly earnings: questions and answers

What is Eli Lilly's net income?

Eli Lilly (LLY) reported net income of $20.64B in fiscal 2025 (the year ended December 31, 2025). That is 94.9% higher than the $10.59B of fiscal 2024.

What is the growth rate of Eli Lilly's net income?

Over the five fiscal years to 2025 net income grew at a compound 27.2% a year; over ten years the rate was 24.0% a year.

What are the highest and lowest net income figures on record for Eli Lilly?

Across the 19 fiscal years on record (2007–2025), the highest was $20.64B in fiscal 2025 and the lowest -$2.07B in fiscal 2008.

How is Eli Lilly's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Eli Lilly (LLY) earnings”, data as of 17 November 2026. https://funkfolio.com/stock/LLY/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.